Eli Lilly
LLY
$3.97 (0.51%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
CNBC • 2 days ago • LLY
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supplyInvestorPlace • 2 days ago • LLY
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in HealthcareCNBC • 2 days ago • LLY
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominanceReuters • 2 days ago • LLY
US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10The Motley Fool • 3 days ago • LLY
Why Eli Lilly Stock Jumped by 4% TodayCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.